Free Trial

Owens & Minor (OMI) Competitors

$17.43
+0.18 (+1.04%)
(As of 05/31/2024 ET)

OMI vs. PDCO, MCK, COR, CAH, HSIC, OPCH, DOCS, CYTK, APLS, and MDGL

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Option Care Health (OPCH), Doximity (DOCS), Cytokinetics (CYTK), Apellis Pharmaceuticals (APLS), and Madrigal Pharmaceuticals (MDGL). These companies are all part of the "medical" sector.

Owens & Minor vs.

Owens & Minor (NYSE:OMI) and Patterson Companies (NASDAQ:PDCO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings.

Patterson Companies has lower revenue, but higher earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.33B0.13-$41.30M-$0.51-34.18
Patterson Companies$6.47B0.34$207.56M$2.0312.11

Patterson Companies has a net margin of 2.95% compared to Owens & Minor's net margin of -0.37%. Patterson Companies' return on equity of 20.98% beat Owens & Minor's return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.37% 12.97% 2.26%
Patterson Companies 2.95%20.98%7.70%

98.0% of Owens & Minor shares are held by institutional investors. Comparatively, 85.4% of Patterson Companies shares are held by institutional investors. 3.6% of Owens & Minor shares are held by company insiders. Comparatively, 1.5% of Patterson Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Owens & Minor currently has a consensus price target of $23.29, indicating a potential upside of 33.60%. Patterson Companies has a consensus price target of $31.67, indicating a potential upside of 28.78%. Given Owens & Minor's higher probable upside, equities analysts clearly believe Owens & Minor is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

Owens & Minor has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.

In the previous week, Patterson Companies had 18 more articles in the media than Owens & Minor. MarketBeat recorded 20 mentions for Patterson Companies and 2 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 1.08 beat Patterson Companies' score of 0.34 indicating that Owens & Minor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Patterson Companies
4 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Patterson Companies received 111 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.39% of users gave Patterson Companies an outperform vote while only 48.54% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
250
48.54%
Underperform Votes
265
51.46%
Patterson CompaniesOutperform Votes
361
52.39%
Underperform Votes
328
47.61%

Summary

Patterson Companies beats Owens & Minor on 13 of the 18 factors compared between the two stocks.

Get Owens & Minor News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.33B$7.55B$5.11B$17.81B
Dividend YieldN/A2.31%2.75%3.55%
P/E Ratio-34.1817.83120.3622.67
Price / Sales0.131.142,428.4511.15
Price / Cash3.3610.6235.0418.95
Price / Book1.492.215.525.90
Net Income-$41.30M$249.27M$105.88M$976.46M
7 Day Performance-0.57%-0.16%1.13%0.62%
1 Month Performance-27.31%-7.07%1.42%4.79%
1 Year Performance-15.22%-4.49%4.04%24.00%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.297 of 5 stars
$24.21
+0.8%
$31.67
+30.8%
-6.1%$2.17B$6.57B11.937,600Analyst Downgrade
Analyst Revision
MCK
McKesson
4.702 of 5 stars
$563.68
+0.9%
$571.47
+1.4%
+45.6%$73.27B$308.95B25.1951,000Insider Selling
Analyst Revision
COR
Cencora
4.2082 of 5 stars
$220.65
+0.7%
$233.90
+6.0%
+33.1%$44.01B$262.17B24.1446,000Insider Buying
CAH
Cardinal Health
4.0695 of 5 stars
$97.59
+1.5%
$107.57
+10.2%
+20.6%$23.77B$205.01B43.3748,000Analyst Downgrade
Short Interest ↓
HSIC
Henry Schein
3.8665 of 5 stars
$70.05
-0.1%
$81.73
+16.7%
-6.2%$8.97B$12.34B23.6725,000Short Interest ↑
Analyst Revision
OPCH
Option Care Health
4.7711 of 5 stars
$30.16
+2.1%
$40.00
+32.6%
+8.2%$5.24B$4.43B19.847,802Short Interest ↑
Positive News
DOCS
Doximity
2.5857 of 5 stars
$28.09
-1.5%
$28.73
+2.3%
-9.6%$5.24B$475.42M39.01977News Coverage
CYTK
Cytokinetics
4.0953 of 5 stars
$48.69
+1.7%
$74.88
+53.8%
+28.7%$5.11B$7.53M-9.02423Analyst Forecast
APLS
Apellis Pharmaceuticals
4.4607 of 5 stars
$40.81
-0.7%
$76.27
+86.9%
-54.3%$4.95B$396.59M-11.79702Analyst Forecast
Analyst Revision
MDGL
Madrigal Pharmaceuticals
4.681 of 5 stars
$225.19
+1.2%
$345.09
+53.2%
-15.2%$4.80BN/A-9.75376Positive News

Related Companies and Tools

This page (NYSE:OMI) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners